 |
|
|
| |
The ASTRAL Studies: Evaluation of SOF/GS-5816 Single-Tablet
Regimen for the Treatment of Genotype 1-6 HCV Infection
|
| |
| |
Reported by Jules Levin
EASL 2015 Vienna Austria
Tarik Asselah,1 Michael Charlton,2 Jordan Feld,3 Graham R. Foster,4 John McNally,5 Diana M. Brainard,5 John G. McHutchison,5 Alessandra Mangia,6 Mark Sulkowski,7 Stefan Zeuzem8
1University Paris Diderot, INSERM U773, Paris, France; 2Intermountain Medical Center, Murray, Utah, USA; 3Toronto Western Hospital, Toronto, Ontario, Canada; 4Queen Mary University of London, London, United Kingdom; 5Gilead Sciences, Inc., Foster City, California, USA; 6Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy; 7Johns Hopkins University, Baltimore, Maryland, USA; 8Johann Wolfgang Goethe University, Frankfurt, Germany
References
1. Jacobson IM, et al. New Engl J Med 2013;368:1867-77;
2. Lawitz E, et al. New Engl J Med 2013;368:1878-87;
3. Cheng G, et al. EASL 2013, poster 1191;
4. German P, et al. EASL 2013, poster 1195;
5. Lawitz E, et al. EASL 2013, poster 1082;
6. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02201940;
7. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02220998;
8. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02201953;
9. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02201901.
|
| |
|
|
|
|
|
